Matches in SemOpenAlex for { <https://semopenalex.org/work/W2495809940> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W2495809940 abstract "Diabetes mellitus exacts a huge toll in money and human suffering. At its present rate of increase, within few decades it will be one of the world's commonest diseases and biggest public-health problem, with an estimated minimum of half-a-billion cases. The diabetic individual is prone to late onset complications that are largely responsible for the morbidity and mortality observed in the patients. It has been demonstrated that the more severe and sustained the degree of hyperglycemia, the more likely it is that the chronic complications of diabetes will develop. Pharmaceutical intervention of hyperglycemia-induced diabetic complications is actively pursued since it is very difficult to maintain normoglycemia by any means in patients with diabetes mellitus. Aldose reductase enzyme (AR, ALR2, E.C. 1.1.1.21) of the polyol metabolic pathway was first found to be implicated in the etiology of secondary complications of diabetes. AR inhibitors (ARIs) have therefore been noted as possible pharmacotherapeutic agents. Although several ARIs have progressed to the clinical level, only one is currently on the market. However, the inhibition of the polyol pathway is considered to be a promising approach to control diabetes complications as well as a number of other pathological conditions like ischemia, abnormal vascular smooth muscle cell proliferation, cancers, and mood disorders. Thus, attention is currently targeted to discover ARIs of distinct chemical structures, being derivatives of neither hydantoin nor carboxylic acid, which are known to cause either toxicity, or posses' narrow spectrum of tissue activity. The focus of this brief overview will aim to support the notion that novel aldose reductase inhibitors with unique physicochemical properties could posses' pharmacotherapeutic potential." @default.
- W2495809940 created "2016-08-23" @default.
- W2495809940 creator A5020424315 @default.
- W2495809940 creator A5026499401 @default.
- W2495809940 creator A5027227036 @default.
- W2495809940 creator A5048453328 @default.
- W2495809940 creator A5085527289 @default.
- W2495809940 date "2007-01-01" @default.
- W2495809940 modified "2023-09-27" @default.
- W2495809940 title "NOVEL CHEMOTYPES IN PHARMACOCHEMICAL APPROACHES Focus on Aldose Reductase Enzyme Inhibitors" @default.
- W2495809940 cites W1518928951 @default.
- W2495809940 cites W1970332005 @default.
- W2495809940 cites W1979580000 @default.
- W2495809940 cites W2004014072 @default.
- W2495809940 cites W2007001142 @default.
- W2495809940 cites W2009571169 @default.
- W2495809940 cites W2013250772 @default.
- W2495809940 cites W2046299832 @default.
- W2495809940 cites W2075344591 @default.
- W2495809940 cites W2079152086 @default.
- W2495809940 cites W2087144995 @default.
- W2495809940 cites W2116542280 @default.
- W2495809940 cites W2121895929 @default.
- W2495809940 cites W2163298135 @default.
- W2495809940 cites W2398091185 @default.
- W2495809940 cites W2950124390 @default.
- W2495809940 hasPublicationYear "2007" @default.
- W2495809940 type Work @default.
- W2495809940 sameAs 2495809940 @default.
- W2495809940 citedByCount "0" @default.
- W2495809940 crossrefType "journal-article" @default.
- W2495809940 hasAuthorship W2495809940A5020424315 @default.
- W2495809940 hasAuthorship W2495809940A5026499401 @default.
- W2495809940 hasAuthorship W2495809940A5027227036 @default.
- W2495809940 hasAuthorship W2495809940A5048453328 @default.
- W2495809940 hasAuthorship W2495809940A5085527289 @default.
- W2495809940 hasConcept C126322002 @default.
- W2495809940 hasConcept C134018914 @default.
- W2495809940 hasConcept C136502266 @default.
- W2495809940 hasConcept C137627325 @default.
- W2495809940 hasConcept C2776439734 @default.
- W2495809940 hasConcept C555293320 @default.
- W2495809940 hasConcept C71924100 @default.
- W2495809940 hasConceptScore W2495809940C126322002 @default.
- W2495809940 hasConceptScore W2495809940C134018914 @default.
- W2495809940 hasConceptScore W2495809940C136502266 @default.
- W2495809940 hasConceptScore W2495809940C137627325 @default.
- W2495809940 hasConceptScore W2495809940C2776439734 @default.
- W2495809940 hasConceptScore W2495809940C555293320 @default.
- W2495809940 hasConceptScore W2495809940C71924100 @default.
- W2495809940 hasLocation W24958099401 @default.
- W2495809940 hasOpenAccess W2495809940 @default.
- W2495809940 hasPrimaryLocation W24958099401 @default.
- W2495809940 hasRelatedWork W1424162772 @default.
- W2495809940 hasRelatedWork W1514740178 @default.
- W2495809940 hasRelatedWork W1929748080 @default.
- W2495809940 hasRelatedWork W2015448112 @default.
- W2495809940 hasRelatedWork W2041673240 @default.
- W2495809940 hasRelatedWork W2073134613 @default.
- W2495809940 hasRelatedWork W2077138908 @default.
- W2495809940 hasRelatedWork W2318618549 @default.
- W2495809940 hasRelatedWork W2393016650 @default.
- W2495809940 hasRelatedWork W2396065203 @default.
- W2495809940 hasRelatedWork W2410942537 @default.
- W2495809940 hasRelatedWork W2489219885 @default.
- W2495809940 hasRelatedWork W2563218373 @default.
- W2495809940 hasRelatedWork W2613715913 @default.
- W2495809940 hasRelatedWork W2949497012 @default.
- W2495809940 hasRelatedWork W2995413889 @default.
- W2495809940 hasRelatedWork W3037825535 @default.
- W2495809940 hasRelatedWork W3097532364 @default.
- W2495809940 hasRelatedWork W3174772161 @default.
- W2495809940 hasRelatedWork W3182650029 @default.
- W2495809940 isParatext "false" @default.
- W2495809940 isRetracted "false" @default.
- W2495809940 magId "2495809940" @default.
- W2495809940 workType "article" @default.